Skip to main content

Want a detailed portfolio tracker?

CBIO P/E (2025 - 2026)

CBIO P/E from Jun 13, 2025 to Jul 20, 2026. The TTM CBIO P/E is -2.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CBIO

YearP/EChange
2026-2.99+10.35%
2025-2.71N/A

Comparison CBIO P/E with competitors

CBIO P/E is -2.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.50%
FGENFibroGen Inc0.24-108.02%
CHRSCoherus Biosciences Inc0.85-128.36%
FBIOFortress Biotech Inc0.95-131.72%
ORMPOramed Pharmaceuticals Inc1.50-150.23%
AGENAgenus Inc3.01-200.58%
INVAInnoviva Inc3.15-205.40%
VXRTVaxart Inc3.55-218.63%
CRMDCorMedix Inc3.63-221.26%
CVACCureVac N.V.4.45-248.57%
GLPGGalapagos NV4.86-262.38%
SRPTSarepta Therapeutics Inc4.88-263.16%
ABEOAbeona Therapeutics Inc5.39-280.05%
ABUSArbutus Biopharma Corp5.60-287.00%
ZVRAZevra Therapeutics Inc5.89-296.75%
SPROSpero Therapeutics Inc6.23-308.15%
CGENCompugen Ltd6.31-311.01%
RIGLRigel Pharmaceuticals6.87-329.66%
SLXNSilexion Therapeutics Corp7.30-343.83%
OMEROmeros Corporation9.26-409.42%
AUPHAurinia Pharmaceuticals Inc9.58-420.32%
PLXProtalix BioTherapeutics Inc10.89-463.97%
ACADAcadia Pharmaceuticals Inc11.73-491.96%
TBPHTheravance Biopharma Inc12.26-509.79%
ADMAAdma Biologics Inc12.42-515.01%
HRMYHarmony Biosciences Holdings Inc13.82-561.86%
SABSSAB Biotherapeutics Inc14.14-572.42%
NAGENiagen Bioscience Inc14.82-595.21%
INCYIncyte Corp15.82-628.78%
REGNRegeneron Pharmaceuticals Inc15.86-629.92%
PBYIPuma Biotechnology Inc17.32-678.68%
CPRXCatalyst Pharmaceuticals Inc17.44-682.81%
EXELExelixis Inc17.54-686.11%
TGTXTG Therapeutics Inc18.97-733.83%
MDXGMimedx Group Inc20.55-786.85%
XOMAXOMA Royalty Corp22.87-864.48%
ARGXArgen X SE24.30-912.04%
CTMXCytomX Therapeutics Inc24.82-929.53%
XOMAOXOMA Royalty Corp25.34-947.03%
HALOHalozyme Therapeutics Inc25.62-956.35%
XOMAPXOMA Royalty Corp25.67-957.90%
VRTXVertex Pharmaceuticals Inc27.99-1035.59%
RPRXRoyalty Pharma plc - Class A28.69-1058.74%
SLNOSoleno Therapeutics Inc29.02-1069.70%
ASNDAscendis Pharma A/S30.09-1105.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1367.03%
APLSApellis Pharmaceuticals Inc39.02-1404.10%
BMRNBiomarin Pharmaceutical Inc42.21-1510.73%
KRYSKrystal Biotech Inc45.34-1615.39%
ONCBeiGene Ltd69.54-2424.06%
PHARPharming Group N.V.75.03-2607.37%
TECHBio-Techne Corp101.96-3507.47%
VCELVericel Corp109.92-3773.60%
ALNYAlnylam Pharmaceuticals Inc117.96-4042.42%
GMABGenmab140.29-4788.55%
TLXTelix Pharmaceuticals Ltd162.15-5519.19%
CORTCorcept Therapeutics Inc212.86-7213.75%